Search

everythinglearnresearchcommunity

for

Search:↓

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

The updated criteria improve the accuracy of diagnosing lupus.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

A gene mutation in Lama3 is linked to a common type of hair loss.

QLT0267 stops hair follicle cell growth and movement.

Cornifin-alpha/SPRR1 is increased in certain skin conditions and by specific treatments.

A 13-year-old boy with a rare genetic condition survived a heart attack and improved with treatment.

The document reports a rare case of ECCL with a new association with optic disc colobomas.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

The document's conclusion cannot be provided because the document is not readable or understandable.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

A unique case showed a rare combination of two types of lichen planus on the face.

New treatments and understanding of skin lupus are emerging in 2024.

MRL/MpJ mice heal burns slower with more scarring and less tissue regeneration than BALB/c mice.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

Low-Level Laser Therapy might be an effective alternative hair loss treatment for some people.

Lokivetmab reduced itching in a dog with skin lymphoma.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

The method shows how hair lipids form specific patterns and their roles in hair structure.

Lipid nanoparticles can help deliver drugs through hair follicles but struggle to penetrate deeper skin layers.